Noxxon Pharma AG - Product Pipeline Review - 2016

  • ID: 3960485
  • Company Profile
  • 36 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Dompe Farmaceutici S.p.A.
  • GlaxoSmithKline Plc
  • Novartis AG
  • Syntrix Biosystems, Inc.
  • MORE
Noxxon Pharma AG - Product Pipeline Review - 2016

The report ‘Noxxon Pharma AG - Product Pipeline Review - 2016’, provides an overview of the Noxxon Pharma AG’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Noxxon Pharma AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Noxxon Pharma AG
- The report provides overview of Noxxon Pharma AG including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Noxxon Pharma AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Noxxon Pharma AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Noxxon Pharma AG’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Noxxon Pharma AG
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Noxxon Pharma AG’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ChemoCentryx, Inc.
  • Dompe Farmaceutici S.p.A.
  • GlaxoSmithKline Plc
  • Novartis AG
  • Syntrix Biosystems, Inc.
  • MORE
Introduction

Noxxon Pharma AG Snapshot

Noxxon Pharma AG Overview

Key Facts

Noxxon Pharma AG - Research and Development Overview

Key Therapeutic Areas

Noxxon Pharma AG - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Noxxon Pharma AG - Pipeline Products Glance

Noxxon Pharma AG - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Noxxon Pharma AG - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Noxxon Pharma AG - Drug Profiles

emapticap pegol - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

lexaptepid pegol - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXD-19 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXD-20 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXD-21 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXG-15 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXG-16 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXL-41 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NOXS-93 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

olaptesed pegol - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Noxxon Pharma AG - Pipeline Analysis

Noxxon Pharma AG - Pipeline Products by Target

Noxxon Pharma AG - Pipeline Products by Route of Administration

Noxxon Pharma AG - Pipeline Products by Molecule Type

Noxxon Pharma AG - Pipeline Products by Mechanism of Action

Noxxon Pharma AG - Dormant Projects

Noxxon Pharma AG - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Noxxon Pharma AG, Key Facts

Noxxon Pharma AG - Pipeline by Indication, 2016

Noxxon Pharma AG - Pipeline by Stage of Development, 2016

Noxxon Pharma AG - Monotherapy Products in Pipeline, 2016

Noxxon Pharma AG - Phase II, 2016

Noxxon Pharma AG - Phase I, 2016

Noxxon Pharma AG - Preclinical, 2016

Noxxon Pharma AG - Pipeline by Target, 2016

Noxxon Pharma AG - Pipeline by Route of Administration, 2016

Noxxon Pharma AG - Pipeline by Molecule Type, 2016

Noxxon Pharma AG - Pipeline Products by Mechanism of Action, 2016

Noxxon Pharma AG - Dormant Developmental Projects,2016

Noxxon Pharma AG, Subsidiaries

List of Figures

Noxxon Pharma AG - Pipeline by Top 10 Indication, 2016

Noxxon Pharma AG - Pipeline by Stage of Development, 2016

Noxxon Pharma AG - Monotherapy Products in Pipeline, 2016

Noxxon Pharma AG - Pipeline by Target, 2016

Noxxon Pharma AG - Pipeline by Route of Administration, 2016

Noxxon Pharma AG - Pipeline by Molecule Type, 2016

Noxxon Pharma AG - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- ChemoCentryx, Inc.
- Dompe Farmaceutici S.p.A.
- GlaxoSmithKline Plc
- Novartis AG
- Syntrix Biosystems, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll